<https://rdf.molmedb.upol.cz/reference/ref1679> <http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM21565>,
		<https://identifiers.org/molmedb/MM469017>;
	<http://purl.org/ontology/bibo/doi> "10.1016/j.bmcl.2006.05.017"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://rdf.molmedb.upol.cz/interaction/method33>,
		<https://identifiers.org/molmedb/MM21565.1>;
	<http://purl.org/ontology/bibo/pmid> "16725323"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM30220>,
		<https://identifiers.org/molmedb/MM30220.1>;
	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/dc/terms/BibliographicResource>;
	<http://purl.org/dc/terms/bibliographicCitation> "Smith G, Mikkelsen G, Eskildsen J, Bundgaard C.: The synthesis and SAR of 2-arylsulfanylphenyl-1-oxyalkylamino acids as GlyT-1 inhibitors. Bioorg Med Chem Lett, Volume 16 (15), 2006"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://rdf.molmedb.upol.cz/interaction/membrane21> .
<https://rdf.molmedb.upol.cz/interaction/int978248> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref1679> .
<https://rdf.molmedb.upol.cz/interaction/int1027814> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref1679> .
<https://rdf.molmedb.upol.cz/interaction/int978511> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref1679> .
<https://rdf.molmedb.upol.cz/interaction/int978260> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref1679> .
